News Archive | Novartis Philippines

Showing 121 results

October 2020

Media Release Oct 08, 2020
Novartis partners with International Agency for the Prevention of Blindness to address eye screening gaps

In celebration of World Sight Day (WSD), Novartis Healthcare Philippines and the International Agency for the Prevention of Blindness (IAPB) launched the multi-stakeholder “Collaboration to…

August 2020

Media Release Aug 11, 2020
Sandoz donates medicines to Philippine Red Cross in support of country’s COVID-19 response

Sandoz Philippines Corporation donated to the Philippine Red Cross (PRC) a year's supply of high-quality Sandoz generic medicines, which will benefit almost 1,000 patients with infections and…

July 2020

Media Release Jul 24, 2020
Novartis partners with De La Salle Medical and Health Sciences Institute to establish Center of Excellence for Clinical Trials

Novartis Healthcare Philippines and De La Salle Medical and Health Sciences Institute (DLSMHSI) have signed a memorandum of agreement (MOA) to establish a Center of Excellence for Clinical Trials…

June 2020

Media Release Jun 25, 2020
COVID-19 response in the Philippines: Novartis contributions

Novartis is taking concrete steps to help ensure sustained supply of essential life-saving medicines to patients and support the country's COVID-19 response led by the Department of Health (DOH).…

May 2020

April 2020

Media Release Apr 30, 2020
Sandoz, Novartis Philippines announce donation of hydroxychloroquine to DOH

Novartis has committed to making a global donation of up to 130 million doses of the anti-malarial drug hydroxychloroquine to support efforts to fight the COVID-19 pandemic. Sandoz Philippines,…

March 2020

Media Release Mar 20, 2020
Novartis in the Philippines: actions to mitigate COVID-19 impact

Novartis continues to closely monitor the COVID-19 situation in Philippines. Company priorities are to protect the health and safety of associates and healthcare professionals, and to ensure…

February 2020

Media Release Feb 17, 2020
Novartis extends financial assistance to 2,500 families affected by Taal Volcano eruption

Novartis Healthcare Philippines extended financial assistance to the Provincial Governments of Batangas and Cavite for the benefit of 2,500 families affected by…

December 2019

Media Release Dec 12, 2019
New study shows early combination treatment with metformin plus vildagliptin better than standard of care in newly diagnosed type 2 diabetes patients

VERIFY study shows early combination therapy of vildagliptin plus metformin provides greater and durable long-term benefits compared with the current standard-of-care initial metformin monotherapy…

September 2019

Media Release Sep 18, 2019
Positive results from Novartis five-year VERIFY study in type 2 diabetes demonstrate long-term clinical benefits of early combination treatment with vildagliptin and metformin

Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes patients 1,2 The landmark VERIFY study is the first to…